The need for the private sector’s economic stewardship of global health is more critical than ever. As geopolitical priorities shift, the life sciences industry has the opportunity and responsibility to help drive sustainable progress, protect communities and secure a brighter economic future by making global health a strategic business priority.
Hosted by Devex in collaboration with Bristol Myers Squibb and CARE, this event will explore how global health investment can move from the periphery of corporate strategy to its core – driving innovation, economic growth and health security. The discussion will highlight why treating global health as a strategic priority, not philanthropy, is essential to both business success and global progress.
We’ll unpack how this investment advances the interests of the life sciences industry by:
Request your invitation to join us on May 21 for a conversation on how the life sciences industry can help drive sustainable progress, protect communities and secure long-term economic growth in the countries where they are based and where they operate by making global health a strategic business priority.
This agenda is evolving and subject to change. Check back for more updates!
Stay tuned for more speaker announcements coming soon!
Deputy vice president for global health and multilateral affairs, PhRMA
Associate vice president, CARE
Chief executive officer, WHO Foundation
Director of government engagement and policy, Access to Medicine Foundation
Vice president and head of population health, Bristol Myers Squibb (BMS)
Executive vice president, Devex